Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer
Authors
Kwon, M.Kim, S. T.
Hong, J. Y.
Kim, G.
Smith, S.
Mortimer, P. G.
LoembE, B.
Dean, Emma J
Kang, W. K.
Lee, J.
Affiliation
Department of Hematology-Oncology, Ajou University, Suwon, South KoreaIssue Date
2022
Metadata
Show full item recordCitation
Kwon M, Kim ST, Hong JY, Kim G, Smith S, Mortimer PG, et al. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680301211.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2022.40.16_suppl.4045Additional Links
https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.4045Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2022.40.16_suppl.4045